BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4398939)

  • 1. Actions of levodopa and dopamine in the central nervous system.
    Sourkes TL
    JAMA; 1971 Dec; 218(13):1909-11. PubMed ID: 4398939
    [No Abstract]   [Full Text] [Related]  

  • 2. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and pharmacological aspects of Parkinsonism.
    Carlsson A
    Acta Neurol Scand Suppl; 1972; 51():11-42. PubMed ID: 4351191
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of various centrally acting agents in mice with unilateral caudate brain lesions.
    Lotti VJ
    Life Sci I; 1971 Jul; 10(14):781-9. PubMed ID: 4329567
    [No Abstract]   [Full Text] [Related]  

  • 5. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.
    Ungerstedt U
    Acta Physiol Scand Suppl; 1971; 367():69-93. PubMed ID: 4332693
    [No Abstract]   [Full Text] [Related]  

  • 6. A model for the quantitative study of central dopaminergic and serotoninergic activity.
    Bieger D; Larochelle L; Hornykiewicz O
    Eur J Pharmacol; 1972 Apr; 18(1):128-36. PubMed ID: 4555562
    [No Abstract]   [Full Text] [Related]  

  • 7. Apomorphine induced biting and fighting behaviour in reserpinized rats and an approach to the mechanism of action.
    Patni SK; Dandiya PC
    Life Sci; 1974 Feb; 14(4):737-45. PubMed ID: 4856759
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic nature of apomorphine-induced pecking in pigeons.
    Cheng HC; Long JP
    Eur J Pharmacol; 1974 May; 26(2):313-20. PubMed ID: 4851427
    [No Abstract]   [Full Text] [Related]  

  • 9. Parkinsonism: animal analogues of the human disorder.
    Duvoisin RC
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():293-303. PubMed ID: 826997
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for a direct action of monamines on the chick central nervous system.
    Spooner CE; Winters WD
    Experientia; 1965 May; 21(5):256-8. PubMed ID: 5294557
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of hyperglycemic response to chlorpromazine administered into lateral ventricle in rats. I. Possible role of dopaminergic nervous system.
    Fujimori K; Iwamoto T
    Neuropharmacology; 1974 Apr; 13(4):245-54. PubMed ID: 4853135
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa in the treatment of Parkinsonism.
    Cotzias GC
    JAMA; 1971 Dec; 218(13):1903-8. PubMed ID: 5171066
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS.
    Ernst AM
    Psychopharmacologia; 1965 May; 7(6):391-9. PubMed ID: 5831877
    [No Abstract]   [Full Text] [Related]  

  • 16. Some benzhydryl derivatives as central dopamine receptor stimulating agents.
    van Beek MC; Timmerman H
    J Pharm Pharmacol; 1974 Jan; 26(1):57-8. PubMed ID: 4150936
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():495-9. PubMed ID: 18898
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S
    Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.